Literature DB >> 3069534

Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.

M Wallensteen1, G Dahlquist, B Persson, M Landin-Olsson, A Lernmark, G Sundkvist, B Thalme.   

Abstract

The pattern of fall in B-cell function measured as plasma and 24 h urinary C-peptide excretion, as well as levels of islet cell antibodies, insulin antibodies and metabolic parameters, were followed for two years in 39 children aged 1-17 years prospectively from clinical onset of Type 1 (insulin-dependent) diabetes. At onset 32/36 patients had measurable plasma C-peptide (median 0.13 nmol/l). Maximum values of fasting and postprandial plasma C-peptide were reached at a median duration of three months. Thereafter both plasma and urinary C-peptide declined linearly. The median value of the rate of fall in postprandial plasma C-peptide was 0.019 nmol.1-1.month-1. Age at onset was positively correlated to the maximum value of postprandial plasma C-peptide in each patient (rs = 0.57, p = 0.0001) and throughout the observation time positively correlated to fasting and postprandial C-peptide and to the 24 h urinary C-peptide excretion (rs range 0.35-0.70, p = 0.03-0.0001). The rate of fall of postprandial C-peptide was unrelated to age at onset and was strikingly parallel in different age groups. Islet cell antibodies were present in 87% of the patients at onset and decreased to 38% at 24 months. Islet cell antibody titres were not correlated to age at onset or to plasma or urinary C-peptide at any single observation. However, islet cell antibody negative patients had significantly higher (p less than 0.05) postprandial plasma C-peptide values at 1, 9, and 12 months of duration, compared to islet cell antibody positive patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069534     DOI: 10.1007/bf00278749

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Radioimmunoelectrophoresis in the determination of insulin binding to IgG.

Authors:  A H Christiansen
Journal:  Horm Metab Res       Date:  1973-05       Impact factor: 2.936

2.  Determination of plasma acetoacetate and D-beta-hydroxybutyrate in new-born infants by an enzymatic fluorometric micro-method.

Authors:  B Persson
Journal:  Scand J Clin Lab Invest       Date:  1970-01       Impact factor: 1.713

3.  Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies.

Authors:  E Bonifacio; A Lernmark; R L Dawkins
Journal:  J Immunol Methods       Date:  1988-01-21       Impact factor: 2.303

4.  Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.

Authors:  W Gepts; J De Mey
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

5.  Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission.

Authors:  J Ludvigsson
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

6.  Islet-cell-surface antibodies in juvenile diabetes mellitus.

Authors:  A Lernmark; Z R Freedman; C Hofmann; A H Rubenstein; D F Steiner; R L Jackson; R J Winter; H S Traisman
Journal:  N Engl J Med       Date:  1978-08-24       Impact factor: 91.245

7.  Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M L Olsson; G Sundkvist; A Lernmark
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

8.  Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man.

Authors:  J H Henriksen; B Tronier; J B Bülow
Journal:  Metabolism       Date:  1987-05       Impact factor: 8.694

9.  beta-cell function in children with diabetes.

Authors:  J Ludvigsson; L G Heding
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

10.  Residual insulin secretion in insulin dependent diabetes mellitus.

Authors:  S Rogers; M Silink
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

View more
  23 in total

1.  Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays.

Authors:  E Bonifacio; C Boitard; H Gleichmann; M A Shattock; J L Molenaar; G F Bottazzo
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

2.  Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.

Authors:  A Kaas; C Pfleger; L Hansen; K Buschard; N C Schloot; B O Roep; H B Mortensen
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 3.  Vaccination against type 1 diabetes.

Authors:  H E Larsson; Å Lernmark
Journal:  J Intern Med       Date:  2011-06       Impact factor: 8.989

4.  Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

Authors:  E Ortqvist; B Brooks-Worrell; K Lynch; J Radtke; L M Bekris; I Kockum; C-D Agardh; C M Cilio; A L Lethagen; B Persson; A Lernmark; J Reichow; S Oak; J P Palmer; C S Hampe
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

5.  Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients.

Authors:  G Sundkvist; L A Velloso; O Kämpe; S L Rabinowe; S A Ivarsson; B Lilja; F A Karlsson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

Review 6.  Immune therapy in type 1 diabetes mellitus.

Authors:  Ake Lernmark; Helena Elding Larsson
Journal:  Nat Rev Endocrinol       Date:  2013-01-08       Impact factor: 43.330

7.  Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study.

Authors:  D Dabelea; E J Mayer-Davis; J S Andrews; L M Dolan; C Pihoker; R F Hamman; C Greenbaum; S Marcovina; W Fujimoto; B Linder; G Imperatore; R D'Agostino
Journal:  Diabetologia       Date:  2012-09-20       Impact factor: 10.122

Review 8.  Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus.

Authors:  A Lernmark; G Klöppel; D Stenger; C Vathanaprida; K Fält; M Landin-Olsson; D G Baskin; J P Palmer; A M Gown; J S Petersen
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children.

Authors:  M Landin-Olsson; J P Palmer; A Lernmark; L Blom; G Sundkvist; L Nyström; G Dahlquist
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

10.  Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.

Authors:  O Snorgaard; S G Hartling; C Binder
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.